Sleek Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance The Finnish Diabetes Prevention Study

被引:87
作者
Tuomilehto, Henri [1 ,3 ]
Keinanen-Kiukaanniemi, Sirkka [11 ]
Peltonen, Markku [4 ]
Ilanne-Parikka, Pirjo [12 ]
Partinen, Markku [5 ,6 ]
Uusitupa, Matti [2 ]
Lavigne, Gilles [3 ]
Tuomilehto, Jaakko [13 ]
Eriksson, Johan G. [4 ,7 ,8 ]
Lindstrom, Jaana [4 ]
Herder, Christian [9 ]
Aunola, Sirkka [10 ]
机构
[1] Kuopio Univ Hosp, Dept Otorhinolaryngol, SF-70210 Kuopio, Finland
[2] Univ Kuopio, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland
[3] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada
[4] Natl Publ Hlth Inst, Diabet Unit, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland
[5] Rinnekoti Res, Skogby Sleep Clin, Espoo, Finland
[6] Univ Helsinki, Dept Neurol, Helsinki, Finland
[7] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland
[8] Vasa Cent Hosp, Vaasa, Finland
[9] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany
[10] Natl Publ Hlth Inst, Lab Populat Res, Helsinki, Finland
[11] Univ Oulu, Inst Hlth Sci, Oulu, Finland
[12] Finnish Diabet Assoc, Ctr Diabet, Tampere, Finland
[13] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
基金
芬兰科学院; 加拿大健康研究院;
关键词
DISEASE RISK; REDUCTION; APNEA; WOMEN;
D O I
10.2337/dc08-1980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Both short and long sleep duration have frequently been found to be associated with an increased risk for diabetes. The aim of the present exploratory analysis was to examine the association between sleep duration and type 2 diabetes after lifestyle intervention in overweight individuals with impaired glucose tolerance in a 7-year prospective follow-up. RESEARCH DESIGN AND METHODS - A total of 522 individuals (aged 40-64 years) were randomly allocated either to an intensive diet-exercise counseling group or to a control group. Diabetes incidence during follow-up was calculated according to sleep duration at baseline. Sleep duration was obtained for a 24-h period. Physical activity, dietary intakes, body weight, and immune mediators (C-reactive protein and interleukin-6) were measured. RESULTS - Interaction between sleep duration and treatment group was statistically significant (P = 0.003). In the control group, the adjusted hazard ratios (HRs) (95% CI) for diabetes were 2.29 (1.38-3.80) and 2.74 (1.67-4.50) in the sleep duration groups 9-9.5 h and >= 10 h, respectively, compared with for that of the 7-8.5 h group. In contrast, sleep duration did not influence the incidence of diabetes in the intervention group; for sleep duration groups 9-9.5 h and >= 10 h, the adjusted HRs (95% CI) were 1.10 (0.60-2.01) and 0.73 (0.34-1.56), respectively, compared with that in the reference group (7-8.5 h sleep). Lifestyle intervention resulted in similar improvement in body weight, insulin sensitivity, and immune mediator levels regardless of sleep duration. CONCLUSIONS - Long sleep duration is associated with increased type 2 diabetes risk. Lifestyle intervention with the aim of weight reduction, healthy diet, and increased physical activity may ameliorate some of this excess risk.
引用
收藏
页码:1965 / 1971
页数:7
相关论文
共 50 条
  • [21] Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance
    Espinoza, Sara E.
    Wang, Chen-pin
    Tripathy, Devjit
    Clement, Stephen C.
    Schwenke, Dawn C.
    Banerji, Mary Ann
    Bray, George A.
    Buchanan, Thomas A.
    Henry, Robert R.
    Kitabchi, Abbas E.
    Mudaliar, Sunder
    Stentz, Frankie B.
    Reaven, Peter D.
    DeFronzo, Ralph A.
    Musi, Nicolas
    AGE, 2016, 38 (5-6) : 485 - 493
  • [22] Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study
    Celik, Cem
    Tasdemir, Nicel
    Abali, Remzi
    Bastu, Ercan
    Yilmaz, Murat
    FERTILITY AND STERILITY, 2014, 101 (04) : 1123 - U568
  • [23] Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes
    Davis, N.
    Forbes, B.
    Wylie-Rosett, J.
    MINERVA MEDICA, 2009, 100 (03) : 221 - 228
  • [24] Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study
    Yu, Liping
    Wang, Jinping
    Gong, Qiuhong
    An, Yali
    Chen, Fei
    Chen, Yanyan
    Chen, XiaoPing
    He, Siyao
    Qian, Xin
    Chen, Bo
    Dong, Fen
    Li, Hui
    Zhao, Fang
    Zhang, Bo
    Li, Guangwei
    DIABETES OBESITY & METABOLISM, 2024, 26 (04) : 1188 - 1196
  • [25] Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study
    Belsti, Yitayeh
    Moran, Lisa J.
    Goldstein, Rebecca
    Mousa, Aya
    Cooray, Shamil D.
    Baker, Susanne
    Gupta, Yashdeep
    Patel, Anushka
    Tandon, Nikhil
    Ajanthan, Saumiyah
    John, Renu
    Naheed, Aliya
    Chakma, Nantu
    Lakshmi, Josyula K.
    Zoungas, Sophia
    Billot, Laurent
    Desai, Ankush
    Bhatla, Neerja
    Prabhakaran, Dorairaj
    Gupta, Ishita
    Kapoor, Deksha
    Praveen, Devarsetty
    Farzana, Noshin
    Enticott, Joanne
    Teede, Helena
    CLINICAL NUTRITION, 2024, 43 (08) : 1728 - 1735
  • [26] Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis
    van Gils, Paul F.
    Lambooij, Mattijs S.
    Flanderijn, Marloes H. W.
    van den Berg, Matthijs
    de Wit, G. Ardine
    Schuit, Albertine J.
    Struijs, Jeroen N.
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 537 - 546
  • [27] The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus
    Dutton, Gareth R.
    Lewis, Cora E.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (01) : 69 - 75
  • [28] Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study
    Chen, Yanyan
    Zhang, Ping
    Wang, Jinping
    Gong, Qiuhong
    An, Yali
    Qian, Xin
    Zhang, Bo
    Li, Hui
    Gregg, Edward W.
    Bennett, Peter H.
    Li, Guangwei
    DIABETOLOGIA, 2021, 64 (06) : 1279 - 1287
  • [29] Primary prevention of type 2 diabetes by lifestyle modification. Results of the PRAEDIAS prevention program
    Kulzer, B.
    Hermanns, N.
    Krichbaum, M.
    Gorges, D.
    Haak, T.
    DIABETOLOGE, 2014, 10 (04): : 276 - +
  • [30] Metformin for Prevention of Type 2 Diabetes - New Results from the Diabetes Prevention Program Study
    Fries, Charlotte
    DIABETOLOGE, 2019, 15 (04): : 344 - 345